Skip to main content
Download PDF

Erratum to: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life

Trials volume 12, Article number: 193 (2011) Cite this article

The Original Article was published on 25 January 2010

Correction

Following the publication of our article [1], we noticed an error regarding the dosage of vitamin B12. In the manuscript, we reported that the daily dosage of vitamin B12 would be 0.4 mg, when in fact the dosage of vitamin B12 used in the B-VITAGE trial is 0.5 mg per day.

In the abstract:

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B12(0.4 mg), B6 (25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

Should read

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B12(0.5 mg), B6 (25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

In the "Intervention and Blinding" section:

Eligible participants will be randomly allocated to treatment with citalopram plus 400 μg vitamin B12, 2 mg folic acid and 25 mg B6 or citalopram plus placebo.

Should read

Eligible participants will be randomly allocated to treatment with citalopram plus 500 μg vitamin B12, 2 mg folic acid and 25 mg B6 or citalopram plus placebo.

References

  1. Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life. Trials. 2010, 11: 8-10.1186/1745-6215-11-8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Western Australian Centre for Health & Ageing, Centre for Medical Research, University of Western Australia, Perth, Australia

    Andrew H Ford, Leon Flicker, Kieran McCaul, Sarah Hegarty, Varsha Hirani & Osvaldo P Almeida

  2. School of Psychiatry & Clinical Neurosciences, University of Western Australia, Perth, Australia

    Andrew H Ford, Sarah Hegarty, Varsha Hirani & Osvaldo P Almeida

  3. Department of Psychiatry, Royal Perth Hospital, Perth, Australia

    Andrew H Ford, Stephen Fenner & Osvaldo P Almeida

  4. School of Medicine & Pharmacology, University of Western Australia, Perth, Australia

    Leon Flicker

  5. Department of Geriatric Medicine, Royal Perth Hospital, Perth, Australia

    Leon Flicker

  6. School of Pathology & Laboratory Medicine, University of Western Australia, Perth, Australia

    Frank van Bockxmeer

  7. Department of Biochemistry, Royal Perth Hospital, Perth, Australia

    Frank van Bockxmeer

Authors
  1. Andrew H Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leon Flicker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kieran McCaul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frank van Bockxmeer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sarah Hegarty
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Varsha Hirani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephen Fenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Osvaldo P Almeida
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Osvaldo P Almeida.

Additional information

The online version of the original article can be found at 10.1186/1745-6215-11-8

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Ford, A.H., Flicker, L., McCaul, K. et al. Erratum to: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life. Trials 12, 193 (2011). https://doi.org/10.1186/1745-6215-12-193

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1745-6215-12-193

Trials

ISSN: 1745-6215